Gonadotropin releasing hormone-1 (GnRH-1) neurons migrate from the developing olfactory pit into the hypothalamus during embryonic development. Migration of the GnRH-1 neurons is required for mammalian reproduction as these cells control release of gonadotropins from the anterior pituitary gland.
Introduction
Gonadotropin Releasing Hormone I neurons (GnRH-1ns) play a pivotal role in controlling the reproductive axis of vertebrates. In the adult, the GnRH-1ns reside within the preoptic hypothalamic area (POA), where they control the hypothalamic-pituitary-gonadal hormonal axis (HPG axis), driving reproductive development and regulating reproductive hormones in adult life (Cattanach et al., 1977) .
During embryonic development, the GnRH-1ns originate in the developing olfactory pit (OP), from which they migrate into the brain and eventually arrive at the hypothalamus Wray et al., 1989a; Wray et al., 1989b) . Disturbances either in this migration or in GnRH-1 synthesis, secretion, and signaling lead to hypogonadotropic hypogonadism (HH), which adversely affects normal sexual development, social interactions, fertility, and propagation of the species Burmeister et al., 2005; Yin and Gore, 2006; Maruska and Fernald, 2011; Zhang et al., 2013) . Around half of all patients affected by HH either have difficulty perceiving odors (hyposmia) or entirely lack the ability to smell altogether (anosmia) (Bianco and Kaiser, 2009; Mitchell et al., 2011) . HH associated with congenital olfactory defects is clinically defined as Kallmann Syndrome (KS).
Developing GnRH-1ns migrate along bundles of olfactory/vomeronasal (VN) and terminal nerve (TN) axons, which project from the nose to the olfactory bulb and POA, respectively. Whether these axons are collectively permissive for migration from the pit to the brain, or whether a specific subpopulation provides instructive guidance cues essential for successful migration has long been controversial. The prevailing idea is that GnRH-1ns access the brain along the olfactory/vomeronasal (VN) sensory fibers, primarily because HH in KS is generally associated with anosmia (Wray, 2010; Boehm et al., 2015; Forni and Wray, 2015) .
Studies based on genetically modified animal models have described GnRH-1ns migratory defects associated with an array of olfactory and vomeronasal sensory neuronal routing deficiencies, either alone or together with atypical formation of the olfactory bulbs (OBs) (Cariboni et al., 2007; Bergman et al., 2010; Cariboni et al., 2011; Cariboni et al., 2012; Hanchate et al., 2012; Messina and Giacobini, 2013; Pingault et al., 2013; Boehm et al., 2015; Cariboni et al., 2015; Lettieri et al., 2016) .
Unilateral and bilateral absence or reduction in the size of OBs, are common phenotypes in Kallmann patients carrying Kal1, CHARGE, trisomy 13 or trisomy 18 mutations, Prok2 or Prok-R2 mutations, and mutations affecting Fgf8 signaling (Ng et al., 2005; Pitteloud et al., 2007; Hardelin and Dode, 2008; Dode and Hardelin, 2010; Teixeira et al., 2010) . Defective projections to the CNS and defective bulb formation have also been described after loss of function of Dlx5, Fezf1, Klf7, Emx2, Lhx2 , genes in mouse (Yoshida et al., 1997; Levi et al., 2003; Long et al., 2003; Yoshihara et al., 2005; Hirata et al., 2006; Chung et al., 2008; Berghard et al., 2012) .
Despite many correlations between olfactory defects and aberrant GnRH-1ns migration, direct experimental evidence proving that olfactory and vomeronasal connections to the OBs are necessary for GnRH-1ns migration to the hypothalamus is lacking. Additionally, in families carrying mutations linked to KS, the two aberrant phenotypes, HH and anosmia, do not necessarily co-segregate. (Leopold et al., 1992; Yousem et al., 1996; Ghadami et al., 2004; Pitteloud et al., 2006; Frasnelli et al., 2007; Balasubramanian et al., 2014) .
Arx-1 is an X linked homeobox gene related to the Drosophila aristaless. Arx-1 loss-of-function leads to a severe form of olfactory bulb aplasia together with abnormal axonal termination of olfactory sensory neurons (Yoshihara et al., 2005) . We have exploited Arx-1 null mutants together with a series of reporter mouse models to test the role of the olfactory system in controlling GnRH-1 migration to the hypothalamus. Our data proves that the establishment of axonal connections of the olfactory and vomeronasal sensory neurons to the brain are not needed for GnRH-1 neuronal migration. In fact, the GnRH-1ns and terminal nerve appear to follow different guidance cues from those controlling the olfactory projections to the OBs.
Material and Methods
Animals: Cryopreserved Arx-1 null mice were resuscitated from the Riken repository. The origins of these mice and their olfactory defects were previously described (Kitamura et al., 2002; Yoshihara et al., 2005) , and our Arx-1 colony was C57 BL/6J mixed background. Because the Arx-1 gene is located on the Xchromosome, Arx-1 hemizygous null mutants were also genotyped for sex to identify male mutants (see below). Arx-1 null mice do not survive past post-natal day 0 (P0), therefore animal cages were checked early in the morning on the day of birth. Embryos of different stages were collected after euthanizing time-mated dams. Peripherin-EGFP (hPRPH1-G) mice were obtained from Dr. J. Sasero (Murdoch Childrens Research Institute, Melbourne Australia) on a C57BL/6J background (McLenachan et al., 2008) . hPRPH1-G Males were mated with Arx-1 females to generate hPRPH1-G /Arx-1 null embryos. GPR12EGFP BAC transgenic mice were resuscitated from GENSAT repository at MMRRC, UC Davis. These mice were obtained on a mixed background. Because EGFP expression in the VNO varied among the F 0-resuscitated animals obtained from GENSAT, we selected a subline (GPR12EGFP 395 ) with persistent strong expression in apical and basal vomeronasal sensory neurons. GPR12EGFP 395 male mice were mated with Arx-1 females to generate Arx-1 null /GPR12EGFP embryos. Animals were euthanized using CO 2 , followed by cervical dislocation. All animal procedures were in accordance with procedures approved by the University at Albany
Institutional Animal Care and Use Committee (IACUC).
Tissue preparation: Embryos were collected from time-mated Arx-1 females, where the emergence of the copulation plug was taken as E0.5. Collected embryos were immersion-fixed in 3.7% Formaldehyde/PBS at 4°C for 3 hours. P0 heads were immersion-fixed in in the same fixative at 4°C for overnight. All samples were then cryoprotected in 30% sucrose overnight or until they sank, then frozen in O.C.T (Tissue-TeK) using dry ice, and kept at -80C. Samples were cryosectioned using CM3050S Leica cryostat and collected on Superfrost plus slides (VWR) at 12-16μm for immunostainings and 18-25 μ m for In Situ Hybridizations (ISH).
Confirmation of animal genotypes:
The genotypes of the mice were established by PCR analysis using the following primers: Arx-1 null (mArx fff: 5'-CGCCC AAGGA AGAGC TGTTG CTGC-3'; ARX pMC1neo stop:
5'-GCCTT CTTGA CGAGT TCTTC-3'; ARX mArx eer 5'TATTC CACCC TCCTG GACCC TTTC-3'); EGFP ( eGFP fwd: 5'-CCTAC GGCGT GCAGT GCTTC AGC-3' ; eGFP REV: 5'CGGCG AGCTG CACGC TGCGT CCTC-3'); Actin 470 (ACTIN SENSE): 5'-CTCGT CTGGGA AAGCA GAAAC TGCAA-3'; ACTIN 470 (ANTISENSE): 5'-GTGAC CTGTT ACTGG GAGTG GCAAG C-3'). Amplification products were analyzed by agarose gel electrophoresis.
Immunohistochemistry. Primary antibodies and dilutions used in this study were: goat-α-neuropilin-1(1:400, R&D Systems), goat-α-neuorpilin-2(1:3000, R&D Systems), goat-α-ROBO1 (1:200, R&D Systems), goat-α-ROBO3(1:50, R&D Systems), mouse-α-ROBO2(1:50, Santa Cruz) chicken-α-peripherin (1:1500, Abcam), rabbit-α-peripherin (1:2000, Millipore), SW rabbit-α-GnRH-1 (1:6000, Susan
Wray, NIH), rabbit-α tyrosine hydroxylase (1:1000, Abcam), goat-α olfactory marker protein (1:4000, WAKO), goat-α transient-axonal glycoprotein 1(1:1000, R&D Systems), rabbit-α-GFP(1:2000, Molecular Probes), chicken-α-GFP (1:1000, Abcam), mouse -α-GAD67 (1:200, Santa Cruz). Antigen retrieval was performed in a citric acid solution prior to incubation with chicken-α-peripherin, rabbit-α-tyrosine hydroxylase, mouse-α-ROBO2, and α -GAD67 antibodies. For immunoperoxidase staining procedures, slides were processed using standard protocols (Forni et al., 2013) and staining was visualized (Vectastain ABC Kit, Vector) using diaminobenzidine (DAB) in a glucose solution containing glucose oxidase to generate hydrogen peroxide; sections were counterstained with methyl green. For immunofluorescence, species-appropriate secondary antibodies were conjugated with Alexa-488, Alexa-594, or Alexa-568 (Molecular Probes and Jackson Laboratories) as specified in the legends. Sections were counterstained with 4′,6′-diamidino-2-phenylindole (1:3000; Sigma-Aldrich) and coverslips were mounted with Fluoro Gel (Electron Microscopy Services). Confocal microscopy pictures were taken on a Zeiss LSM 710 microscope. Epifluorescence pictures were taken on a Leica DM4000 B LED fluorescence microscope equipped with a Leica DFC310 FX camera. Images were further analyzed using FIJ/ImageJ software.
X-gal Staining. Sections were rehydrated in PBS and then incubated in a solution of 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 2 mM MgCl 2 , 0.1% Tween, and 0.1% 5-bromo-4-chloro-3-indolyl-b-D-galactoside/dimethylformamide at 37°C O.N. After the enzymatic reaction was completed, slides were either counterstained with 1% Eosin-Y (Electron Microscopy Services) or washed and immunostained as described above.
In situ hybridization. Digoxigenin-labeled cRNA probes were prepared by in vitro transcription (DIG RNA labeling kit; Roche Diagnostics) from the following templates: Semaphorins 3A, (Kagoshima and Ito, 2001 );
Slits-1, as well as Robo-2, Robo-3 (Cloutier et al., 2004) . In situ hybridization was performed as described (Forni et al., 2013) and visualized by immunostaining with an alkaline phosphatase conjugated anti-DIG
(1:1000), and NBT/BCIP developer solution (Roche Diagnostics). Sections were then counterimmunostained with antibodies against both chicken-α-peripherin, and SW rabbit-α-GnRH-1, as described above for immunofluorescence.
Quantification and statistical analyses of microscopy data. Cell counts were done on serial sections immunostained for GnRH-1 and visualized under bright field (immunoperoxidase) or epi-fluorescence illumination (20×; Leica DM4000 B LED), according to their anatomical location [i.e., (1) nasal region (VNO, axonal tracks surrounding the olfactory pits, forebrain junction); (2) olfactory bulb/fibrocellular mass; and (3) brain (all the cells that accessed the olfactory bulb and were distributed within the forebrain)]. For each animal, counts were performed on 3 serial series. The average number of cells from these 3 series was then multiplied by the total number of series/animal to compute a value for each animal. These were then averaged (± standard error) among animals of the same age and genotype. Means ± SEs were calculated on at least three animals per genotype. A two-tailed, non-paired Student's t-test was used to assess differences between mutant and wild type controls for each group. P≤ 0.05 was considered statistically significant.
Mapping the Distribution of GnRH-1 Neurons: Whole heads of P0 Arx-1 null mutants and controls (n=3;3)
were cryosectioned at 16μm thickness. The sections were then immunostained against GnRH-1 in DAB and counterstained with methyl green. The most medial 16 sections (8 sections from either side of the midline cartilage) were scanned at 10x using a VS120 Olympus scanning microscope in brightfield. Sections were aligned in PhotoShop CS6 using the median eminence, cerebellum, and ventricles as landmarks. Cell bodies were marked and overlaid, representing a cross section of their migratory path. The coordinates of each cell body were plotted in reference to the origin (x=0;y=0), which was set at the middle of the median eminence, using FIJI. The number of GnRH-1ns distributed along the x-axis (rostro-caudal) were quantified in 500μm intervals for each animal. Differences at each interval between genotypes was assessed by unpaired t-Test.
Results
Arx-1 mutants lack proper olfactory bulb formation
As previously described in detail by Yoshihara and coworkers (Yoshihara et al., 2005) , Arx-1 null mice develop a severe bulb aplasia/hypoplasia secondary to the defective proliferation, migration, and maturation of interneuron progenitors and precursors into the OB. Periglomerular cells and granule cells are two major types of GABAergic interneurons in the OB (Mugnaini et al., 1984; Kosaka et al., 1995; Kiyokage et al., 2017) . Tyrosine hydroxylase (TH) is expressed by sets of periglomerular cells and cells of the molecular layer. Olfactory nerve input is required for the normal expression of tyrosine hydroxylase (TH) in the main olfactory bulb (Kawano and Margolis, 1982; Ehrlich et al., 1990; Stone et al., 1990) .
Control mice immunostained for olfactory marker protein (OMP; to label olfactory and vomeronasal neurons and axons) and TH revealed the normal projections and active connections of olfactory/vomeronasal axons (Fig. 1A ,C,I,K). In Arx-1null animals, the olfactory fibers were found tangled in a large fibro-cellular mass (FCM; Fig. 1B ,D,J,L) and no TH immunoreactivity was found in the OBs (Fig. 1J ,L).
Immunostaining against glutamic acid decarboxylase-67 (GAD67) (Mugnaini et al., 1984; Carleton et al., 2003) , highlighted the well-organized GABAergic neurons in the OB of control animals ( Fig. 1M ). In Arx-1 mutants most of the GAD67 positive neurons could not enter the OB and accumulated ventral and at the rostral end of the RMS (Fig. 1N ). However, comparable TH and GAD67 immunoreactivity was found in the striatum of WT and Arx-1 null mutants (Fig 1I, J, M, N, asterisks) .
In the Arx-1 null mice, two exons have been replaced by the β-galactosidase gene (Kitamura et al., 2002) .
By performing X-Gal staining on Arx-1 null mutants and Arx-1 +/-controls ( Fig. 1E ,F), we confirmed the migratory defects of the interneuron progenitors as reported by (Yoshihara et al., 2005) together with the absence of Arx-1 expression in the olfactory epithelium and in GnRH-1 neurons ( Fig. 1G ,H).
Aberrant olfactory development does not affect GnRH-1 migration to the basal forebrain
GnRH-1 neurons start to invade the brain region between E11.5 and E12.5 and complete their migration in about 5 days. We analyzed Arx-1 null mice and wild type controls at E13.5 and E15.5, which are stages in which the GnRH-1 neurons are still migrating, and at the completion of embryonic development, P0.
Double immunolabeling against OMP and GnRH-1 ( Fig revealed that despite the dramatic tangling of the olfactory and vomeronasal fibers observed in the Arx-1 null mutants, the GnRH-1ns were nonetheless able to bypass the tangle and access the brain (Fig. 2B ,D,J). In both controls and Arx-1 null mutants, the GnRH-1ns were seen migrating to the brain along OMP-negative fibers ( Fig. 2C,D) .
Quantification of total GnRH-1 numbers at E13.5 (WT=715±87; KO=676±38; n=3), E15.5 (WT=727±76; KO=725±39; n=4) and P0 (WT=576±82; KO=661±99; n=3) indicated there were no differences between genotypes at any of the analyzed stages (data ±SE, unpaired t-test P>0.05).
To establish if the GnRH-1 neurons migrate in the brain at a different rate in Arx-1 mutants when compared to control animals, we quantified the distributions of GnRH-1ns between the nasal area and the brain at E13.5, E15.5, and P0 (Fig. 2K ). This analysis revealed no difference among genotypes (Fig. 2K ).
Even in wild type mice, a subset of GnRH-1ns never reach the preoptic/hypothalamic area, but instead remain in the nasal area or form rings around the OBs (Casoni et al., 2016) . Quantification of GnRH-1 neurons in the olfactory bulb/forebrain junction and brain ( Fig. 2L ), indicated that both at E15.5 (not shown) and P0, a similar number of GnRH-1ns remains in the FCM in Arx-1 null mutants compared with those found around the OBs in controls (Fig. 2L ).
Performing a detailed mapping of GnRH-1 distribution in control and Arx-1 null mutants at P0, we observed comparable distribution of the GnRH-1 neurons, from the entry point, ventral to the olfactory bulbs, to the caudal hypothalamus, proximal to the median eminence ( Fig. 3 ) to controls. However, the GnRH-1 cells in the Arx-1 mutants appeared to be less scattered along the dorso-ventral axis when compared to controls (Fig. 3C,D) .
Thus, our analyses at these developmental stages argued that during embryonic development the GnRH1ns migrate into the forebrain at comparable rate as in control mice, regardless of the severity of the olfactory bulb aplasia and the dramatic defects in olfactory axonal termination.
The fibers upon which the GnRH-1 neurons access the brain are distinct from the olfactory fibers.
Immunostaining for endogenous Peripherin in mice is usually used to highlight axons of cranial nerves, including those of the olfactory/vomeronasal and terminal nerves (TN/cranial nerve 0) (Wray et al., 1994; Yoshida et al., 1995; Schwanzel-Fukuda, 1999; Casoni et al., 2016) . Thus, one of the major technical limitations in developmental studies of GnRH-1ns is the lack of molecular markers able to selectively label neuronal subpopulations in the nasal area. While analyzing the hPRPH1-G BAC transgenic line, which expresses EGFP under control of a human Peripherin gene promoter (McLenachan et al., 2008) , we observed in the nasal area that expression of the hPeripherin:EGFP fusion protein was not fully consistent with that of the endogenous mouse gene. Whereas the endogenous mouse Peripherin protein was readily detectable by immunostaining for Peripherin on OSNs, VSNs, and on fibers forming the GnRH-1 migratory pathway (Fig. 4H,I ,O), hPRPH1-EGFP expression was strong only in putative VSNs projecting to the accessory olfactory bulb (AOB) and in TN neurons and barely detectable in OSNs projecting to the main olfactory bulb (MOB) (Fig. 4A ,B,J,L). Immunostaining against TAG-1, which was previously found to highlight neurons forming the GnRH-1 migratory scaffold (Yoshida et al., 1995; Casoni et al., 2016) , and
GnRH-1 confirmed that the EGFP+ fibers projecting to the basal forebrain were fibers of the presumptive TN ( Fig. 4C-G ).
To validate that the GnRH-1ns follow the same migratory route in Arx-1 null mutants and controls, we exploited the stronger selective EGFP expression of the hPRPH1-G BAC transgenic line in VN and TN fibers ( Fig. 4H-M ).
In line with what was observed after OMP/GnRH-1 immunolabeling (Fig. 2) , immunolabeling against EGFP and OMP on hPRPH1-G mutant mouse sections (Fig. 4K,M) indicated that the fibers, upon which the GnRH-1 access the brain either did not express OMP or expressed it below immunodetectable levels. To follow selectively the trajectories of the putative TN in controls and Arx-1 null mice we generated hPRPH1-G +/-/ Arx-1 null embryos (Fig. 4K,M,O) . Observations on these embryos revealed that the TN projections accessing the brain were positive for hPRP1-G expression, as was seen in control animals (Fig. 4J,L) while the hPRP1-G expressing vomeronasal sensory axons were tangled as part of the FCM (Fig. 4K,M 
,O).
The TN fibers are distinct from apical and basal vomeronasal sensory neurons.
Whereas some earlier researchers had proposed that GnRH-1ns reach the hypothalamus on a set of vomeronasal (VN) fibers that diverge from those that project to the accessory olfactory bulb (AOB) (Wray et al., 1989a; Yoshida et al., 1995) , others argued instead that GnRH-1ns migrate along axons of the elusive terminal nerve (TN), which initially forms bundles with the vomeronasal axons until they diverge Vilensky, 2012; Zhao et al., 2013; Casoni et al., 2016) . To resolve this discrepancy, we searched for genetic markers that could distinguish among the various subpopulations of axons resident in the nasal regions where GnRH-1ns migrate. The vomeronasal organ itself (VNO) is composed of apical and basal subpopulations of sensory neurons (VSNs). Both subpopulations project to the AOB, but they differ in their final targets, expression of adhesion molecules, Semaphorin receptors (Neuropilins), Slit receptors (Robos), VN receptors, G-protein subunits, and glycoproteins (Schwarting et al., 1994; Francia et al., 2014; Perez-Gomez et al., 2014) . Whereas the apical neurons project to the anterior (a) portion of the AOB, the basal neurons project to the posterior (p) AOB. The neuronal branch upon which GnRH-1ns migrate shares transient expression of glycoproteins expressed by the basal, but not the apical VSNs (Yoshida et al., 1995) . By analyzing microarray data obtained from vomeronasal tissue, data (not shown), we found that the G-protein coupled receptor GPR12, which is a high-affinity receptor for sphingosylphosphorylcholine (Ignatov et al., 2003) , is expressed in the developing VNO (data not shown, In
Situ available at Eurexpress.org). We next tested whether an EGFP-tagged version of GPR12 could be used to selectively label the vomeronasal axons, using the GENSAT GPR12-EGFP (Tg(Gpr12-EGFP) LD58Gsat) BAC transgenic mouse line. Analysis of these mice (Fig. 5) indicated that indeed the vomeronasal neurons, along with a few, sparse olfactory and microvillar neurons in the main olfactory epithelium (data not shown), expressed GPR12 from embryonic to postnatal stages. Immunostaining with two markers that can distinguish apical from basal VSNs, Gαo (not shown) and Gαi2 (Chamero et al., 2012) , revealed that GPR12-EGFP was expressed in both the apical and basal VSNs, which respectively project to the anterior (a) and posterior (p) portions of the AOB (Fig. 5A-C) . By immunostaining sections from these mice at E15.5 (n=3; Fig. 5D-F) for GnRH-1, Peripherin, and NRP2, we found that fibers of the TN were genetically distinct from these axons. Moreover, migrating GnRH-1ns were found to deviate from the GPR12-EGFP+ vomeronasal bundles projecting to the AOB (Fig. 5D ) and to access the brain along Peripherin positive fibers negative for GPR12-EGFP, consistent with the presence of distinct TN fibers (Fig.   5F ). Furthermore, the GPR12-EGFP expression allowed us to confirm that NRP2 expression was limited to the olfactory and apical VSN axons (Fig. 5E ). In addition to the GnRH-1ns, we also observed sporadic migratory cells expressing GPR12 in their cell body migrating together with the GnRH-1ns (data not shown).
By mating Arx-1 null females with GPR12-EGFP males, we generated Arx-1 null /GPR12-EGFP +/-mice and GPR12-EGFP +/-controls. Using these mice, we could selectively follow the trajectory of developing vomeronasal sensory fibers in the absence of proper olfactory bulb development by examining embryos at E15.5 and at birth (P0). In the Arx-1 mutants at P0 (Fig. 5G,G1 ), the VSNs axons formed a tangle within the FCM, surrounded by olfactory fibers. Analysis of Arx-1 null /GPR12-EGFP +/-embryos at E15.5 by immunostaining for EGFP in combination with GnRH-1, Peripherin, NRP2 (Fig. 5H-K) confirmed that the GnRH-1ns crossed the FCM and accessed the brain along neurons negative for GPR12EGFP.
Collectively, these data showed that the axons of the TN are genetically distinct from vomeronasal axons, and are used by GnRH-1ns to access the brain.
The GnRH-1 neurons and terminal nerve differ from the vomeronasal fibers for guidance receptors expression.
The key regulators of olfactory axonal routing and targeting are the Class-3 Semaphorins, Neuropilin receptors (NRP-1 and NRP-2), Slit1, Slit2, and Roundabout (Robo) receptors (Renzi et al., 2000; Schwarting et al., 2000; Walz et al., 2002; Takeuchi et al., 2010; Cho et al., 2012) . Slit and Sema3 proteins prevent olfactory fibers from invading the brain prior to OB formation (Renzi et al., 2000) . Immunostaining against the Sema receptors NRP-1 and NRP-2 on hPRPH1-G +/-mice showed that during GnRH-1 neuronal migration, NRP1 and NRP2 were strongly expressed by olfactory sensory neurons, projecting to the main olfactory (MOB) and by vomeronasal sensory neurons projecting to the accessory olfactory bulb, respectively ( Fig. 6A-F) . However, TN fibers, which are strongly EGFP+ in these mice, exhibited only weak NRP1 expression and no detectable NRP2 expression (Fig. 6A-F) . Similarly, in Arx-1 null /hPRPH1-G double mutants, we observed that NRP1 and NRP2 were expressed by the olfactory and vomeronasal fibers in the FCM, whereas the EGFP+ fibers of the TN expressed NRP1 only weakly, and no detectable NRP2 ( Fig.   6G-H2 ).
To further understand the relationship between the aberrant olfactory/vomeronasal trajectories and successful GnRH-1 migration in Arx-1 null mutants, we performed in situ hybridization against the diffusible guidance cues Semaphorin 3A (Sema3A). By combining this digoxigenin-based in situ hybridization with double immunofluorescence for Peripherin and GnRH-1, we could follow the TN trajectory with respect to this guidance cue in the brain.
Analysis of WT animals at E13.5 and E15.5 consistently showed the TN and the GnRH-1ns invade the brain ventral and between the developing OBs in a region positive for Sema3A expression (Fig. 6I1-K2 ).
Consistent with observations in WT, analysis of Arx-1 null mutants at E15.5 showed that the FCM, which is mainly formed by NRP1+ fibers (Fig. 6G-G2 ) collapsed in close proximity with meninges positive for Sema3A expression (Fig. 6K,K1) . However, the GnRH-1 neurons and TN were found to be able to penetrate the brain and to project towards and across sources of Sema3A ( Fig. 6K1-2 ).
The GnRH-1 neurons and terminal nerve respond differently from the olfactory and vomeronasal fibers to sources of Slit1 in the brain.
Slit proteins play a pivotal role in repelling Robo1+ and Robo2+ olfactory and vomeronasal neurons and in preventing them from invading the brain (Renzi et al., 2000; Nguyen-Ba-Charvet et al., 2008) .
Consistent with this report, we observed, by in situ hybridization at E15.5, that both the olfactory and vomeronasal neurons expressed Robo2 (Fig. 7B1) . Similarly, immunofluorescence confirmed detectable Robo2 expression in axons of the developing OSNs as well as in subsets of VSN projecting to the OB and tangled in the FCM of the Arx-1 Null mutants (Fig. 8H,I ). Also, Robo1 expression was detected in putative olfactory ensheathing cells (OECs) (Aoki et al., 2013) surrounding the olfactory bulb in controls and surrounding the FCM in Arx-1 null mutants (Fig. 7A1-3, Fig. 8F ,G). Consistent with a repellant role for Slit proteins in repelling Robo1+ and Robo2+ axons, in situ hybridization for Slit1 on controls and Arx-1 null mutants revealed strong Slit1 expression in the cortex as well as in the basal forebrain (Fig.8 A-E3 ).
In sharp contrast to the OSNs and VSNs, neither the GnRH-1ns nor the terminal nerve expressed detectable levels of either Robo1 (Fig. 7A1-3, Fig. 8F ,G) or Robo2 (Fig. 7B2-4) .
A third member of the Robo gene family of receptors, Robo3, does not bind Slit proteins, but various isoforms of Robo3 can silence Slit-mediated repulsion if they are co-expressed with Robo1 or Robo2 (Sabatier et al., 2004; Zelina et al., 2014) . In-situ hybridization and immunohistochemistry against Robo3 revealed barely detectable levels of Robo3 expression in olfactory and vomeronasal neurons, but axons of the terminal nerve were strongly positive for Robo3 protein expression (Fig. 7E3-4) . Furthermore, Robo3 mRNA was strongly expressed in cell bodies forming a ganglionic structure proximal to the VNO in the nasal area (Fig. 7C1 ). Robo3 immunostaining of GPR12-EGFP embryos confirmed that this staining was not in VSN cell bodies ( Fig. 7C2-3 ). In the nasal region, Robo3 fibers comingled with GPR12-EGFP+ VSN fibers, and Peripherin immunostaining confirmed strong immunoreactivity for Robo3 on the fibers of the putative TN (Fig. 7C2-3 ,E1-6). Migrating GnRH-1ns were found along Robo3-expressing axons ( Fig. 7D1-3 ).
To follow the trajectories of the OSN and VSNs with respect to sources of Slit in the brain at E13.5 and E15.5, we coupled in-situ hybridization against Slit1 with Peripherin and GnRH-1 immunofluorescence. At both stages, the OSN/VSNs contacted the brain in areas negative for Slit1 expression, which correspond to the putative olfactory bulb primordia ( Fig. 8A1-2,C,D2 ). However, in Arx-1 null mutants, where the OBs fail to form properly, we found Slit1 to be expressed in a continuum throughout the cortex and basal forebrain ( (Fig 8B1-3 ,E2,C), the TN and GnRH-1 neurons appeared to be able to invade the brain and to migrate across sources of Slit1 (Fig 8 A3,B3 , D3,E3).
Collectively, these results (see summary in Fig. 8 .C and J) suggest that GnRH-1ns migrate from the nose to the brain along axons of the TN. Our experiments indicate that routing of the axonal projections of the TN is defined by signaling mechanisms distinct from those controlling olfactory and vomeronasal targeting to the main and accessory olfactory bulbs.
Discussion
After the initial description of Kallmann syndrome (Kallmann FJ, 1944) and subsequent discovery that GnRH-1ns migrate from the nose to the brain Wray et al., 1989a; Wray et al., 1989b) , a link between olfactory development and GnRH-1 migration was proposed, investigated, and accepted (Cariboni et al., 2007; Toba et al., 2008; Wray, 2010; Lewkowitz-Shpuntoff et al., 2012) . This found further support in: 1) evidence indicating that the GnRH-1ns originate from the olfactory placode; 2) a correlation between HH and mutations in genes affecting innervation of the olfactory bulbs; 3)
analyses of mice carrying mutation in guidance signals that can affect olfactory development (Wierman et al., 2011; Forni and Wray, 2015 (Balmer and LaMantia, 2004; Imai et al., 2009 ).
Despite the brain defects, aberrant olfactory bulb formation, and the extreme misrouting of olfactory/vomeronasal axons, the GnRH-1 neuron's migratory rate as well as their ability to reach the preoptic/hypothalamic areas was not obviously altered in Arx-1 mutants. Arx-1 loss affects normal development of the brain (Friocourt et al., 2006; Simonet et al., 2015) , therefore, some differences in how cells scatter in the brain could reflect brain abnormalities (Fig.3) . These results indicate that correct targeting of olfactory and vomeronasal axons to the OB plays no direct role in defining the rate, and routing of GnRH-1ns migration into the forebrain. Instead, GnRH-1ns appeared to migrate along the axons of the TN to access the brain.
By exploiting hPRPH-1G and GPR12-EGFP BAC transgenics we revealed a distinction between the TN and the olfactory and vomeronasal sensory neurons. The GPR12-EGFP BAC transgenic was found to be selectively expressed by VSNs, few olfactory neurons, but not by the TN neurons. Though we cannot exclude that some of the cell bodies of the TN might be within the developing VNO, our data points to a distinct genetic identity for this nerve from the VSNs (Yoshida et al., 1995) .
A small number of GnRH-1ns was found to fail to enter the brain in the FCM of Arx-1 null mutants. However, even in normal animals, a similar number of GnRH-1ns migrate on fibers projecting to the OB (Casoni et al., 2016) . This suggests the existence of a subpopulation of GnRH-1ns that invariably migrates to the OB along specific neurons that must genetically differ from the majority that migrate along projections to the hypothalamus. If the GnRH-1ns that migrate to the OBs (Casoni et al., 2016) play active roles in olfaction is a possibility that should be further investigated.
Strengthening the idea that the TN and not the olfactory/vomeronasal fibers provides the scaffold for GnRH1ns migration, we showed that these different subpopulations of axons follow different guidance cues.
Targeting of axons in general is defined by a complex interplay of attractive and repulsive signals, which in the case of olfactory fibers, are released by the olfactory/vomeronasal epithelia, nasal mesenchyme, and the olfactory bulb (Schwarting et al., 2000; Cloutier et al., 2002; Cloutier et al., 2004; Cho et al., 2007; Prince et al., 2009; Cho et al., 2012; Brignall and Cloutier, 2015) . An array of GnRH-1 migratory defects, with varying severity, occurs in genetically modified animal models where axonal misrouting and/or defasciculation of olfactory neurons also occurs (Matsumoto et al., 2006; Cariboni et al., 2011; HernandezMiranda et al., 2011; Messina et al., 2011; Cariboni et al., 2012; Barraud et al., 2013; Pingault et al., 2013; Cariboni et al., 2015; Tillo et al., 2015) . However, discriminating between cell-autonomous and secondary effects of mutations of the genes linked to KS in humans (e.g., prokineticin-2, prokineticin receptor-2, Fgf8, Fgf8-Receptor-1, Semaphorin3A, Semaphorin7A, Sox10, and CHD7) is made difficult by the broad number of tissue/cell types affected (Hanchate et al., 2012; Lewkowitz-Shpuntoff et al., 2012) . Semaphorin 3A, NRP1, NRP2, Slit proteins, and the receptor Robo3 have all been previously implicated in guiding olfactory axons and GnRH-1ns Cariboni et al., 2012) .
By performing in situ hybridization against Sema3A and Slit1 on control and Arx-1 null mice we confirmed that the forebrain is a large source of repellent molecules, which in concert, might prevent the olfactory and vomeronasal fibers, but not the TN nor the GnRH-1ns, from invading the brain (Renzi et al., 2000; NguyenBa-Charvet et al., 2008) . As shown previously, we observed that the Sema3 receptors, NRP1 and NRP2, are expressed by olfactory and vomeronasal neurons projecting to different regions of the MOB and AOB (Cloutier et al., 2002; Walz et al., 2002; Cloutier et al., 2004; Taku et al., 2016) ; however we could only detect NRP1 but not NRP2 immuno-reactivity on GnRH-1ns and TN axons Hanchate et al., 2012; Giacobini and Prevot, 2013; Giacobini, 2015) . By performing in situ hybridization against Sema3A in combination with immunofluorescence for GnRH-1 and Peripherin, we observed that the TN and GnRH-1 invade the brain crossing a source of Sema3A.
Loss of Sema3A expression compromises both olfactory/vomeronasal axon trajectories as well as those of the TN, along with GnRH-1ns migration. The effects of class 3 Semaphorins on growth cone trajectories varies according to Sema3 concentration, NRP expression levels, and levels of cyclic nucleotides, which can selectively favor growth cone attraction vs. repulsion (Song et al., 1998; Pond et al., 2002; Manns et al., 2012) . In Arx-1 mutants, NRP1+ and NRP2+ olfactory and VSNs axons collapsed proximal to the brain as part of the FCM (Fig. 6 ), whereas in both wild type and Arx-1 null mutants, the TN projected towards a source of Sema3A. These observations, together with the phenotype of Sema3A KO, where TN and GnRH-1 fail to invade the brain Giacobini and Prevot, 2013) , suggest that Sema3A may prevent olfactory and vomeronasal fibers from invading the brain while attracting GnRH-1ns and TN fibers.
Robo1,2 receptors cause axonal collapse in response to Slit proteins, whereas Robo3, depending on the isoform, can silence Slit repulsion (Chen et al., 2008) . In line with previous studies, we found that both olfactory neurons and subsets of vomeronasal neurons express Robo2, along with low levels of Robo1 and Robo3. In mice lacking Robo1,2 the olfactory fibers invade the forebrain, following a route similar to that followed by the TN (Nguyen-Ba-Charvet et al., 2008). However, despite significant olfactory defects, Robo1
and Robo2 double mutants have no GnRH-1 migratory defects (Cariboni et al., 2012) . Also, our data on WT and Arx-1 null mutants showed that the cortex and basal forebrain are large sources of Slit1, and that the GnRH-1ns, in contrast to the olfactory and vomeronasal axons, cross sources of Slit proteins in the forebrain (Fig. 8) . In line with these observations, TN and GnRH-1ns (data not shown) are negative for Robo1 and Robo2 expression, but positive for Robo3. A previous study described defects in GnRH-1 migration in Robo3 null animals, which was proposed to be in response to Robo3 binding Slit2 (Cariboni et al., 2012) and would seem to contradict our findings. However, Robo3 is now known to bind NELL2 and not Slit proteins (Camurri et al., 2005; Zelina et al., 2014; Jaworski et al., 2015) . Therefore, defective GnRH-1 migration in Robo3 mutants could result from the inability of TN and GnRH-1ns to respond to NELL2 mediated guidance.
Our conclusion that the TN, and not the olfactory/vomeronasal sensory neurons, provides the scaffold for GnRH-1ns migration, is supported by comparative phylogenetic studies. For example, although the VNO is absent in birds, amphibians, and fish (Smith and Bhatnagar, 2000; Dulac and Torello, 2003) , GnRH-1ns and the TN connecting the nose to the brain are present in these species Ridgway et al., 1987; Muske and Moore, 1988; Mousley et al., 2006; Zhao et al., 2013) . Moreover, the TN provides the only connection between the nasal area and the brain in toothed whales (Odontoceti), animals in which the GnRH-1ns reach the brain but the VNO, OE, and OBs fail to form (Buhl and Oelschlager, 1986; Ridgway et al., 1987) .
Our work has shown, for the first time, that the invasion of the brain by migrating GnRH-1ns is independent from the correct targeting of the olfactory and vomeronasal neurons to the OBs. Although an impaired sense of smell, absence or reduction of olfactory bulb volume are all common diagnostic parameters for Kallmann Syndrome, our work suggests that neither defects in olfactory bulb development nor aberrant olfactory/vomeronasal axonal routing are sufficient to prevent the migration of GnRH-1ns into the basal forebrain. The pathophysiological overlap between Kallmann syndrome and normosmic IHH in humans (Lewkowitz-Shpuntoff et al., 2012) implies, that although the development of the TN/GnRH-1 system and the olfactory system may rely on partially overlapping guidance cues, they follow different molecular mechanisms. To reach a full understanding of the molecular mechanisms leading to KS and normosmic IHH, the community should now attempt to isolate and fully characterize the cells of the TN nerve in different animal systems and humans. in the POA and their A2,B2) projections (arrows) to the ME (D=dorsal, V=ventral, R=rostral, C=caudal) .
Mapping of the GnRH-1ns distribution in Arx-1 WT (n=3) and null (n=3) mice was performed on one series from each animal. C-D) Scatter plots illustrating GnRH-1ns distribution in WT (C) (n=3) and KO (n=3) 
